What we do
We are a science-led global healthcare company. We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 86 manufacturing sites in 36 countries and large R&D centres in the UK, USA, Spain, Belgium and China.
In March 2015 we completed a 3-part transaction with Novartis which reshapes our business.
We acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our Consumer Healthcare businesses to create a new company. By substantially strengthening Vaccines and Consumer Healthcare, we can deliver far-reaching benefits to patients and consumers, and further value to shareholders. In addition, Novartis acquired our marketed Oncology portfolio.
Find out more about our other sectors
We make a wide range of prescription medicines to treat many acute and chronic diseases. This is the main area of our business accounting for around 67% of our global turnover. In 2013 we distributed more than 860 million vaccine doses to 170 countries – making our vaccines business one of the largest in the world.
Our consumer healthcare products are divided into four categories: Total Wellness, Oral Care, Nutrition and Skin Health and include many well-known brands including Sensodyne, Panadol and Horlicks.